We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+2.16%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$34.7B
AUM Growth
+$242M
(+0.7%)
Cap. Flow
-$120M
Cap. Flow
% of AUM
-0.35%
Top 10 Holdings %
Top 10 Hldgs %
14.95%
Holding
3,089
New
65
Increased
2,336
Reduced
597
Closed
54
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$47.6M |
| 2 |
Medtronic
MDT
|
+$41.4M |
| 3 |
SLB Ltd
SLB
|
+$25M |
| 4 |
American Airlines Group
AAL
|
+$19.2M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$18.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$107M |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$68.5M |
| 3 |
Apple
AAPL
|
+$22.9M |
| 4 |
CFN
CAREFUSION CORPORATION
CFN
|
+$16.9M |
| 5 |
PETM
PETSMART INC
PETM
|
+$14M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.74% |
| 2 | Financials | 14.67% |
| 3 | Healthcare | 14.62% |
| 4 | Industrials | 10.93% |
| 5 | Consumer Discretionary | 9.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALXN
126
DELISTED
Alexion Pharmaceuticals
ALXN
| $58M | 0.17% |
334,415
-479
| -0.1% | -$86.7K |
|
127
Deere & Co
DE
$160B
| $57.7M | 0.17% |
658,344
+17,794
| +3% | +$1.58M |
|
128
Yum! Brands
YUM
$42.2B
| $57.4M | 0.17% |
1,014,238
-16,546
| -2% | -$903K |
|
129
Regeneron Pharmaceuticals
REGN
$78.5B
| $57.2M | 0.17% |
126,791
-1,386
| -1% | -$587K |
|
130
Illinois Tool Works
ITW
$82.6B
| $56.9M | 0.16% |
586,174
-31,836
| -5% | -$3.07M |
|
131
Prudential Financial
PRU
$42.4B
| $56.6M | 0.16% |
705,152
-14,900
| -2% | -$1.21M |
|
132
Baxter International
BAX
$13.5B
| $56.4M | 0.16% |
1,515,415
-24,142
| -2% | -$915K |
|
133
LyondellBasell Industries
LYB
$20B
| $56.3M | 0.16% |
640,927
-24,242
| -4% | -$2.04M |
|
134
Chubb
CB
$135B
| $56M | 0.16% |
502,294
+3,298
| +0.7% | +$371K |
|
135
Stryker
SYK
$125B
| $55.5M | 0.16% |
601,498
-9,260
| -2% | -$862K |
|
136
CSX Corp
CSX
$93.4B
| $55.4M | 0.16% |
5,022,201
-52,860
| -1% | -$608K |
|
137
Public Storage
PSA
$60.5B
| $55M | 0.16% |
279,014
-18,048
| -6% | -$3.57M |
|
138
Ecolab
ECL
$78.1B
| $54.2M | 0.16% |
474,257
-4,984
| -1% | -$546K |
|
|
SCHW
139
Charles Schwab
SCHW
$183B
| $54M | 0.16% |
1,774,425
-12,890
| -0.7% | -$374K |
|
140
Kroger
KR
$35.4B
| $54M | 0.16% |
1,408,566
-61,972
| -4% | -$2.21M |
|
|
MRSH
141
Marsh
MRSH
$90.5B
| $53.6M | 0.15% |
956,173
+72,381
| +8% | +$4.08M |
|
142
Norfolk Southern
NSC
$75.4B
| $53.5M | 0.15% |
519,984
-9,217
| -2% | -$986K |
|
143
Valero Energy
VLO
$92.9B
| $53.3M | 0.15% |
837,884
-20,275
| -2% | -$1.13M |
|
144
Johnson Controls International
JCI
$88.8B
| $52.4M | 0.15% |
992,541
-12,871
| -1% | -$654K |
|
145
CME Group
CME
$96.3B
| $52.1M | 0.15% |
550,623
-58,780
| -10% | -$5.45M |
|
146
Air Products & Chemicals
APD
$65.7B
| $51.6M | 0.15% |
368,916
-5,832
| -2% | -$807K |
|
147
PPG Industries
PPG
$24.6B
| $51.1M | 0.15% |
452,970
-10,460
| -2% | -$1.2M |
|
148
Becton Dickinson
BDX
$45.6B
| $51M | 0.15% |
364,230
+10,478
| +3% | +$1.47M |
|
|
RTN
149
DELISTED
Raytheon Company
RTN
| $49.9M | 0.14% |
456,723
-3,570
| -0.8% | -$384K |
|
150
Equity Residential
EQR
$24.9B
| $49.5M | 0.14% |
636,356
+41,960
| +7% | +$3.28M |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2015 Portfolio in Review
As of Q1 2015, RhumbLine Advisers held 3,089 positions worth $34.7B, up 0.7% from $34.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Trading was light in Q1 2015: portfolio turnover was 3.9%. RhumbLine Advisers opened 65 new positions and exited 54, leaving the 3,089-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q1 2015 buy was Qorvo: 254,331 shares worth $20.3M.
- RhumbLine Advisers added most to Allergan plc in Q1 2015, an estimated $47.6M increase.
- RhumbLine Advisers's biggest Q1 2015 reduction was Apple, cutting an estimated $22.9M.
- RhumbLine Advisers fully exited Allergan Inc in Q1 2015, selling an estimated $107M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $34.7B portfolio in Q1 2015.
- RhumbLine Advisers opened 65 new positions and closed 54 in Q1 2015.
- RhumbLine Advisers's portfolio value rose 0.7% quarter-over-quarter to $34.7B.
Based on RhumbLine Advisers's 13F filing for Q1 2015, filed 12 May 2015.